The Community Guide

- gsearch

Search Results

Narrow Results:

on behalf of Country Experts 1

Journal Article 61
Letter 8

1 - 20 of 69 Results

Refine Results

Refine Results:

Children

CITE Title : Children Personal Author(s) : Brown, Mary Jean;Falk, Henry;Frumkin, Howard; Published Date : Jan 2007 Source : Environ Health Perspect. 2007; 115(1):A17. URL : https://stacks.cdc.gov/view/cdc/27748 Brown, Mary Jean et al. (2007). Children. 115(1). Brown, Mary Jean and Falk, Henry and Frumkin, Howard "Children" 115, no. 1 (2007) Brown, Mary Jean et al. "Children" vol. 115, no. 1, 2007 Export RIS Citation Information.

:

Brown, Mary Jean ;

Falk, Henry

Jan 2007 | Environ Health Perspect. 2007; 115(1):A17.

No Description
Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel

CITE Title : Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel Personal Author(s) : Glatman-Freedman, Aharona;Bromberg, Michal;Hershkovitz, Yael;Sefty, Hanna;Kaufman, Zalman;Dichtiar, Rita;Keinan-Boker, Lital; Published Date : 5 2022 Source : Emerg Infect Dis. 2022; 28(5):948-956 URL : https://stacks.cdc.gov/view/cdc/117303 Glatman-Freedman, Aharona et al. (2022). Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel. 28(5). Glatman-Freedman, Aharona et al. "Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel" 28, no. 5 (2022) Glatman-Freedman, Aharona et al. "Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel" vol. 28, no. 5, 2022 Export RIS Citation Information.

:

Glatman-Freedman, Aharona ;

Bromberg, Michal

5 2022 | Emerg Infect Dis. 2022; 28(5):948-956

:

We estimated vaccine effectiveness (VE) of the BNT162b2 (Pfizer-BioNTech, https://www.pfizer.com) booster dose against SARS-CoV-2 infection and reduct...
Infant Botulism, Israel, 2007–2021

CITE Title : Infant Botulism, Israel, 2007–2021 Personal Author(s) : Goldberg, Bar;Danino, Dana;Levinsky, Yoel;Levy, Itzhak;Straussberg, Rachel;Dabaja-Younis, Halima;Guri, Alex;Almagor, Yotam;Tasher, Diana;Elad, Daniel;Baider, Zina;Blum, Shlomo;Scheuerman, Oded; Published Date : 2 2023 Source : Emerg Infect Dis. 2023; 29(2):235-241 URL : https://stacks.cdc.gov/view/cdc/127638 Goldberg, Bar et al. (2023). Infant Botulism, Israel, 2007–2021. 29(2). Goldberg, Bar et al. "Infant Botulism, Israel, 2007–2021" 29, no. 2 (2023) Goldberg, Bar et al. "Infant Botulism, Israel, 2007–2021" vol. 29, no. 2, 2023 Export RIS Citation Information.

:

Goldberg, Bar ;

Danino, Dana

2 2023 | Emerg Infect Dis. 2023; 29(2):235-241

:

Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laborator...
Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17

CITE Title : Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17 Personal Author(s) : Adlhoch, Cornelia;Dabrera, Gavin;Penttinen, Pasi;Pebody, Richard; Corporate Authors(s) : on behalf of Country Experts Published Date : Oct 17 2018 Source : Emerg Infect Dis. 24(10). URL : https://stacks.cdc.gov/view/cdc/59462 Adlhoch, Cornelia et al. (2018). Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17. 24(10). Adlhoch, Cornelia et al. "Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17" 24, no. 10 (2018) Adlhoch, Cornelia et al. "Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016–17" vol. 24, no. 10, 2018 Export RIS Citation Information.

:

Adlhoch, Cornelia ;

Dabrera, Gavin

Oct 17 2018 | Emerg Infect Dis. 24(10).

:

We sought to better understand national approaches for managing potential human health risks during outbreaks of infection with avian influenza A(H5N8...
Coronavirus Disease Spread during Summer Vacation, Israel, 2020

CITE Title : Coronavirus Disease Spread during Summer Vacation, Israel, 2020 Personal Author(s) : Somekh, Ido;Simões, Eric A. F.;Somekh, Eli; Published Date : 1 2022 Source : Emerg Infect Dis. 2022; 28(1):188-191 URL : https://stacks.cdc.gov/view/cdc/113315 Somekh, Ido et al. (2022). Coronavirus Disease Spread during Summer Vacation, Israel, 2020. 28(1). Somekh, Ido and Simões, Eric A. F. and Somekh, Eli "Coronavirus Disease Spread during Summer Vacation, Israel, 2020" 28, no. 1 (2022) Somekh, Ido et al. "Coronavirus Disease Spread during Summer Vacation, Israel, 2020" vol. 28, no. 1, 2022 Export RIS Citation Information.

:

Somekh, Ido ;

Simões, Eric A. F.

1 2022 | Emerg Infect Dis. 2022; 28(1):188-191

:

The relative increase in coronavirus disease incidence during summer 2020 in Israel was most prominent in young children. This finding contrasts with ...
Zika Virus Disease in Traveler Returning from Vietnam to Israel

CITE Title : Zika Virus Disease in Traveler Returning from Vietnam to Israel Personal Author(s) : Meltzer, Eyal;Lustig, Yaniv;Leshem, Eyal;Levy, Ran;Gottesman, Giora;Weissmann, Rotem;Rabi, Duha Hejleh;Hindiyeh, Musa;Koren, Ravit;Mendelson, Ella;Schwartz, Eli; Published Date : Aug 15 2016 Source : Emerg Infect Dis. 22(8):1521-1522. URL : https://stacks.cdc.gov/view/cdc/40876 Meltzer, Eyal et al. (2016). Zika Virus Disease in Traveler Returning from Vietnam to Israel. 22(8). Meltzer, Eyal et al. "Zika Virus Disease in Traveler Returning from Vietnam to Israel" 22, no. 8 (2016) Meltzer, Eyal et al. "Zika Virus Disease in Traveler Returning from Vietnam to Israel" vol. 22, no. 8, 2016 Export RIS Citation Information.

:

Meltzer, Eyal ;

Lustig, Yaniv

Aug 15 2016 | Emerg Infect Dis. 22(8):1521-1522.

No Description
Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019

CITE Title : Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 Personal Author(s) : Ron, Merav;Brosh-Nissimov, Tal;Korenman, Zinaida;Treygerman, Orit;Sagi, Orli;Valinsky, Lea;Rokney, Assaf; Published Date : 1 2022 Source : Emerg Infect Dis. 2022; 28(1):118-126 URL : https://stacks.cdc.gov/view/cdc/113319 Ron, Merav et al. (2022). Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019. 28(1). Ron, Merav et al. "Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019" 28, no. 1 (2022) Ron, Merav et al. "Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019" vol. 28, no. 1, 2022 Export RIS Citation Information.

:

Ron, Merav ;

Brosh-Nissimov, Tal

1 2022 | Emerg Infect Dis. 2022; 28(1):118-126

:

Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and ...
Postvaccination COVID-19 among Healthcare Workers, Israel

CITE Title : Postvaccination COVID-19 among Healthcare Workers, Israel Personal Author(s) : Amit, Sharon;Beni, Sharon Alexsandra;Biber, Asaf;Grinberg, Amir;Leshem, Eyal;Regev-Yochay, Gili; Published Date : February 01 2021 Source : Emerg Infect Dis. 27(4):1220-1222 URL : https://stacks.cdc.gov/view/cdc/104884 Amit, Sharon et al. (2021). Postvaccination COVID-19 among Healthcare Workers, Israel. 27(4). Amit, Sharon et al. "Postvaccination COVID-19 among Healthcare Workers, Israel" 27, no. 4 (2021) Amit, Sharon et al. "Postvaccination COVID-19 among Healthcare Workers, Israel" vol. 27, no. 4, 2021 Export RIS Citation Information.

:

Amit, Sharon ;

Beni, Sharon Alexsandra

February 01 2021 | Emerg Infect Dis. 27(4):1220-1222

:

Coronavirus disease (COVID-19) symptoms can be mistaken for vaccine-related side effects during initial days after immunization. Among 4,081 vaccinate...
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021

CITE Title : Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021 Personal Author(s) : Glatman-Freedman, Aharona;Hershkovitz, Yael;Kaufman, Zalman;Dichtiar, Rita;Keinan-Boker, Lital;Bromberg, Michal; Published Date : 11 2021 Source : Emerg Infect Dis. 27(11):2919-2922 URL : https://stacks.cdc.gov/view/cdc/111460 Glatman-Freedman, Aharona et al. (2021). Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021. 27(11). Glatman-Freedman, Aharona et al. "Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021" 27, no. 11 (2021) Glatman-Freedman, Aharona et al. "Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021" vol. 27, no. 11, 2021 Export RIS Citation Information.

:

Glatman-Freedman, Aharona ;

Hershkovitz, Yael

11 2021 | Emerg Infect Dis. 27(11):2919-2922

:

In Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly befo...
West Nile fever outbreak, Israel, 2000: epidemiologic aspects.

CITE Title : West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Personal Author(s) : Weinberger, M.;Pitlik, S. D.;Gandacu, D.;Lang, R.;Nassar, F.;Ben David, D.;Rubinstein, E.;Izthaki, A.;Mishal, J.;Kitzes, R.;Siegman-Igra, Y.;Giladi, M.;Pick, N.;Mendelson, E.;Bin, H.;Shohat, T.; Published Date : 2001 Jul-Aug Source : Emerg Infect Dis. 7(4):686-691. URL : https://stacks.cdc.gov/view/cdc/15186 Weinberger, M. et al. (2001). West Nile fever outbreak, Israel, 2000: epidemiologic aspects.. 7(4). Weinberger, M. et al. "West Nile fever outbreak, Israel, 2000: epidemiologic aspects." 7, no. 4 (2001) Weinberger, M. et al. "West Nile fever outbreak, Israel, 2000: epidemiologic aspects." vol. 7, no. 4, 2001 Export RIS Citation Information.

:

Weinberger, M. ;

Pitlik, S. D.

2001 Jul-Aug | Emerg Infect Dis. 7(4):686-691.

:

From August 1 to October 31, 2000, 417 cases of West Nile (WN) fever were serologically confirmed throughout Israel; 326 (78%) were hospitalized patie...
Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel.

CITE Title : Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel. Personal Author(s) : Hindiyeh, M.;Shulman, L. M.;Mendelson, E.;Weiss, L.;Grossman, Z.;Bin, H.; Published Date : 2001 Jul-Aug Source : Emerg Infect Dis. 7(4):748-750. URL : https://stacks.cdc.gov/view/cdc/15193 Hindiyeh, M. et al. (2001). Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel.. 7(4). Hindiyeh, M. et al. "Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel." 7, no. 4 (2001) Hindiyeh, M. et al. "Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel." vol. 7, no. 4, 2001 Export RIS Citation Information.

:

Hindiyeh, M. ;

Shulman, L. M.

2001 Jul-Aug | Emerg Infect Dis. 7(4):748-750.

:

We report the isolation of West Nile (WN) virus from four patient serum samples submitted for diagnosis during an outbreak of WN fever in Israel in 20...
Increased Extent of and Risk Factors for Pandemic (H1N1) 2009 and Seasonal Influenza among Children, Israel

CITE Title : Increased Extent of and Risk Factors for Pandemic (H1N1) 2009 and Seasonal Influenza among Children, Israel Personal Author(s) : Engelhard, Dan;Bromberg, Michal;Averbuch, Diana;Tenenbaum, Ariel;Goldmann, Daniele;Kunin, Marina;Shmueli, Einat;Yatsiv, Ido;Weintraub, Michael;Mandelboim, Michal;Strauss-Liviatan, Nurith;Anis, Emilia;Mendelson, Ella;Shohat, Tamy;Wolf, Dana G.;Shapiro, Mervyn;Grotto, Itamar; Published Date : Sep 2011 Source : Emerg Infect Dis. 17(9):1740-1743. URL : https://stacks.cdc.gov/view/cdc/23687 Engelhard, Dan et al. (2011). Increased Extent of and Risk Factors for Pandemic (H1N1) 2009 and Seasonal Influenza among Children, Israel. 17(9). Engelhard, Dan et al. "Increased Extent of and Risk Factors for Pandemic (H1N1) 2009 and Seasonal Influenza among Children, Israel" 17, no. 9 (2011) Engelhard, Dan et al. "Increased Extent of and Risk Factors for Pandemic (H1N1) 2009 and Seasonal Influenza among Children, Israel" vol. 17, no. 9, 2011 Export RIS Citation Information.

:

Engelhard, Dan ;

Bromberg, Michal

Sep 2011 | Emerg Infect Dis. 17(9):1740-1743.

:

During the pandemic (H1N1) 2009 outbreak in Israel, incidence rates among children were 2× higher than that of the previous 4 influenza seasons; hosp...
Clinical characteristics of the West Nile fever outbreak, Israel, 2000.

CITE Title : Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Personal Author(s) : Chowers, M. Y.;Lang, R.;Nassar, F.;Ben-David, D.;Giladi, M.;Rubinshtein, E.;Itzhaki, A.;Mishal, J.;Siegman-Igra, Y.;Kitzes, R.;Pick, N.;Landau, Z.;Wolf, D.;Bin, H.;Mendelson, E.;Pitlik, S. D.;Weinberger, M.; Published Date : 2001 Jul-Aug Source : Emerg Infect Dis. 7(4):675-678. URL : https://stacks.cdc.gov/view/cdc/15184 Chowers, M. Y. et al. (2001). Clinical characteristics of the West Nile fever outbreak, Israel, 2000.. 7(4). Chowers, M. Y. et al. "Clinical characteristics of the West Nile fever outbreak, Israel, 2000." 7, no. 4 (2001) Chowers, M. Y. et al. "Clinical characteristics of the West Nile fever outbreak, Israel, 2000." vol. 7, no. 4, 2001 Export RIS Citation Information.

:

Chowers, M. Y. ;

Lang, R.

2001 Jul-Aug | Emerg Infect Dis. 7(4):675-678.

:

West Nile (WN) virus is endemic in Israel. The last reported outbreak had occurred in 1981. From August to October 2000, a large-scale epidemic of WN ...
Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel

CITE Title : Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel Personal Author(s) : Glatman-Freedman, Aharona;Hershkovitz, Yael;Dichtiar, Rita;Rosenberg, Alina;Keinan-Boker, Lital;Bromberg, Michal; Published Date : 4 2023 Source : Emerg Infect Dis. 2023; 29(4):771-777 URL : https://stacks.cdc.gov/view/cdc/127656 Glatman-Freedman, Aharona et al. (2023). Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel. 29(4). Glatman-Freedman, Aharona et al. "Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel" 29, no. 4 (2023) Glatman-Freedman, Aharona et al. "Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel" vol. 29, no. 4, 2023 Export RIS Citation Information.

:

Glatman-Freedman, Aharona ;

Hershkovitz, Yael

4 2023 | Emerg Infect Dis. 2023; 29(4):771-777

:

We assessed effectiveness of the BNT162b2 vaccine against infection with the B.1.1.529 (Omicron) variant (mostly BA.1 subvariant), among children 5-11...
substances and childhood neurodevelopment

CITE Title : substances and childhood neurodevelopment Personal Author(s) : Spratlen, Miranda J;Perera, Frederica P;Lederman, Sally Ann;Rauh, Virginia A;Robinson, Morgan;Kannan, Kurunthachalam;Trasande, Leonardo;Herbstman, Julie; Published Date : 8 2020 Source : Environ Pollut. 263(Pt B):114444 URL : https://stacks.cdc.gov/view/cdc/90694 Spratlen, Miranda J et al. (2020). substances and childhood neurodevelopment. 263 Spratlen, Miranda J et al. "substances and childhood neurodevelopment" 263 (2020) Spratlen, Miranda J et al. "substances and childhood neurodevelopment" vol. 263, 2020 Export RIS Citation Information.

:

Spratlen, Miranda J ;

Perera, Frederica P

8 2020 | Environ Pollut. 263(Pt B):114444

:

Perfluoroalkyl substances (PFAS) were among various persistent organic pollutants suspected to have been released during the collapse of the World Tra...
Hepatitis C Virus Elimination Program among Prison Inmates, Israel

CITE Title : Hepatitis C Virus Elimination Program among Prison Inmates, Israel Personal Author(s) : Eisen, Lihi;Mor, Zohar;Madar, Miriam;Rabinovitch, Ron;Dadon, Yuval;Sheffer, Rivka;Kaliner, Ehud;Goldstein, Liav; Published Date : 11 2023 Source : Emerg Infect Dis. 2023; 29(11):2358-2361 URL : https://stacks.cdc.gov/view/cdc/135974 Eisen, Lihi et al. (2023). Hepatitis C Virus Elimination Program among Prison Inmates, Israel. 29(11). Eisen, Lihi et al. "Hepatitis C Virus Elimination Program among Prison Inmates, Israel" 29, no. 11 (2023) Eisen, Lihi et al. "Hepatitis C Virus Elimination Program among Prison Inmates, Israel" vol. 29, no. 11, 2023 Export RIS Citation Information.

:

Eisen, Lihi ;

Mor, Zohar

11 2023 | Emerg Infect Dis. 2023; 29(11):2358-2361

:

The Israeli Prison Services implemented a hepatitis C virus (HCV) elimination program in 2020. Inmates considered high risk for HCV were offered serol...
Imported Melioidosis, Israel, 2008

CITE Title : Imported Melioidosis, Israel, 2008 Personal Author(s) : Cahn, Avivit;Koslowsky, Benjamin;Nir-Paz, Ran;Temper, Violeta;Hiller, Nurit;Karlinsky, Alla;Gur, Itzhak;Hidalgo-Grass, Carlos;Heyman, Samuel N.;Moses, Allon E.;Block, Colin; Published Date : Nov 2009 Source : Emerg Infect Dis. 15(11):1809-1811. URL : https://stacks.cdc.gov/view/cdc/17819 Cahn, Avivit et al. (2009). Imported Melioidosis, Israel, 2008. 15(11). Cahn, Avivit et al. "Imported Melioidosis, Israel, 2008" 15, no. 11 (2009) Cahn, Avivit et al. "Imported Melioidosis, Israel, 2008" vol. 15, no. 11, 2009 Export RIS Citation Information.

:

Cahn, Avivit ;

Koslowsky, Benjamin

Nov 2009 | Emerg Infect Dis. 15(11):1809-1811.

:

In 2008, melioidosis was diagnosed in an agricultural worker from Thailand in the southern Jordan Valley in Israel. He had newly diagnosed diabetes me...
Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

CITE Title : Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel Published Date : Jul 2009 Source : Emerg Infect Dis. 15(7):1116-1118. URL : https://stacks.cdc.gov/view/cdc/17357 "Epidemiology of Human T-cell" (2009). 15(7). "Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel" 15, no. 7 (2009) "Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel" vol. 15, no. 7, 2009 Export RIS Citation Information.

Jul 2009 | Emerg Infect Dis. 15(7):1116-1118.

:

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors...
Molecular Characterization of Tickborne Relapsing Fever Borrelia, Israel

CITE Title : Molecular Characterization of Tickborne Relapsing Fever Borrelia, Israel Personal Author(s) : Assous, Marc Victor;Wilamowski, Amos;Bercovier, Herve;Marva, Esther; Published Date : Nov 2006 Source : Emerg Infect Dis. 12(11):1740-1743. URL : https://stacks.cdc.gov/view/cdc/16415 Assous, Marc Victor et al. (2006). Molecular Characterization of Tickborne Relapsing Fever Borrelia, Israel. 12(11). Assous, Marc Victor et al. "Molecular Characterization of Tickborne Relapsing Fever Borrelia, Israel" 12, no. 11 (2006) Assous, Marc Victor et al. "Molecular Characterization of Tickborne Relapsing Fever Borrelia, Israel" vol. 12, no. 11, 2006 Export RIS Citation Information.

:

Assous, Marc Victor ;

Wilamowski, Amos

Nov 2006 | Emerg Infect Dis. 12(11):1740-1743.

No Description
Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel.

CITE Title : Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Personal Author(s) : Keysary, A.;Amram, L.;Keren, G.;Sthoeger, Z.;Potasman, I.;Jacob, A.;Strenger, C.;Dawson, J. E.;Waner, T.; Published Date : 1999 Nov-Dec Source : Emerg Infect Dis. 5(6):775-778. URL : https://stacks.cdc.gov/view/cdc/14916 Keysary, A. et al. (1999). Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel.. 5(6). Keysary, A. et al. "Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel." 5, no. 6 (1999) Keysary, A. et al. "Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel." vol. 5, no. 6, 1999 Export RIS Citation Information.

:

Keysary, A. ;

Amram, L.

1999 Nov-Dec | Emerg Infect Dis. 5(6):775-778.

:

We conducted a retrospective serosurvey of 1,000 persons in Israel who had fever of undetermined cause to look for Ehrlichia chaffeensis antibodies. F...

1 - 20 / 69